Improved treatment of systemic blood infections using antibiotics with extracorporeal opsonin hemoadsorption

Biomaterials

Volumn 67, Issue , 2015, Pages 382-392

  Didar, Tohid F ^a,b   Cartwright, Mark J ^a   Rottman, Martin ^a,d   Graveline, Amanda R ^a   Gamini, Nazita ^a   Watters, Alexander L ^a   Leslie, Daniel C ^a,b   Mammoto, Tadanori ^b   Rodas, Melissa J ^a   Kang, Joo H ^a   Waterhouse, Anna ^a   Seiler, Benjamin T ^a   Lombardo, Patrick ^a   Qendro, Elisabet I ^a   Super, Michael ^a   Ingber, Donald E ^a,b,c  

^a HARVARD UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Bio functional hollow fibers; Combined drug device therapy for sepsis; Dialysis like treatment (DLT) of sepsis; Pathogen and LPS endotoxin cleansgin; Sytematic blood infections

Indexed keywords

ANTIBIOTICS; CONTROLLED DRUG DELIVERY; DIALYSIS; ESCHERICHIA COLI; PATHOGENS; RATS;

BLOOD INFECTION; COMBINED DRUG-DEVICE THERAPY FOR SEPSIS; EXTRACORPOREAL THERAPY; HOLLOW FIBER; INFLAMMATORY RESPONSE; MANNOSE BINDING LECTINS; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES;

BLOOD;

ABSORBENT; ANTIBIOTIC AGENT; CYTOKINE; ENDOTOXIN; FC DOMAIN LINKED MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN; OPSONIN; POLYETHERSULFONE; POLYSULFONE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL LOAD; BIOCOMPATIBILITY; BLOOD SAMPLING; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; DIALYSIS EQUIPMENT AND SUPPLIES; ESCHERICHIA COLI; EXTRACORPOREAL HEMOADSORPTION; EXTRACORPOREAL HEMOADSORPTION FILTER; HEMADSORPTION; HEMODIALYSIS; HEMOPERFUSION; HUMAN; IN VITRO STUDY; LIVER; LUNG; MALE; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; RAT; SEPSIS; SEPTIC SHOCK; SPLEEN; STAPHYLOCOCCUS AUREUS; ADSORPTION; ANIMAL; BACTERIAL INFECTIONS; CHO CELL LINE; CRICETULUS; EXTRACORPOREAL CIRCULATION; HAMSTER; HEMOFILTRATION; WISTAR RAT;

ANIMALIA; CANDIDA ALBICANS; ESCHERICHIA COLI; FUNGI; NEGIBACTERIA; RATTUS; STAPHYLOCOCCUS AUREUS;

ADSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHO CELLS; CRICETINAE; CRICETULUS; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HUMANS; LIPOPOLYSACCHARIDES; MALE; OPSONIN PROTEINS; RATS, WISTAR;

EID: 84939621978     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.07.046     Document Type: Article

References (41)

1. Anas A.A., Wiersinga W.J., de Vos A.F., van der Poll T. Recent insights into the pathogenesis of bacterial sepsis. Neth. J. Med. 2010, 68:147-152.
2. Azevedo L.C. Sepsis pathogenesis: how many pieces are there in the puzzle?. Endocr. Metab. Immun. Disord. Drug Targets 2010, 10:188-189.
3. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
4. Focus on sepsis. Nat. Med. 2012, 18:997.
5. Heffner A.C., Horton J.M., Marchick M.R., Jones A.E. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2010, 50:814-820.
6. Gille-Johnson P., Hansson K.E., Gardlund B. Severe sepsis and systemic inflammatory response syndrome in emergency department patients with suspected severe infection. Scand. J. Infect. Dis. 2013, 45:186-193.
7. Lineaweaver W., Howard R., Soucy D., McMorris S., Freeman J., Crain C., et al. Topical antimicrobial toxicity. Arch. Surg. 1985, 120:267-270.
8. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intens. Care Med. 2012, 2013(39):165-228.
9. Shorr A.F., Micek S.T., Welch E.C., Doherty J.A., Reichley R.M., Kollef M.H. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit. Care Med. 2011, 39:46-51.
10. Davies B., Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect. Dis. 2011, 11:65-71.
11. Armstrong L., Medford A.R., Hunter K.J., Uppington K.M., Millar A.B. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol. 2004, 136:312-319.
12. Tsujimoto H., Ono S., Majima T., Kawarabayashi N., Takayama E., Kinoshita M., et al. Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 2005, 23:39-44.
13. Ishikawa M., Miyauchi T., Yagi K., Chikaishi H., Fukuta Y., Miyake H., et al. Clinical relevance of antibiotic-induced endotoxin release in patients undergoing hepatic resection. World J. Surg. 1999, 23:75-79.
14. Prins J.M., van Deventer S.J., Kuijper E.J., Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob. Agents Chemother. 1994, 38:1211-1218.
15. Lepper P.M., Held T.K., Schneider E.M., Bolke E., Gerlach H., Trautmann M. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intens. Care Med. 2002, 28:824-833.
16. Holzheimer R.G. Antibiotic induced endotoxin release and clinical sepsis: a review. J. Chemother. 2001, 13:159-172. Spec No 1.
17. Ronco C. Recent evolution of renal replacement therapy in the critically ill patient. Crit. Care 2006, 10:123.
18. Reiter K., D'Intini V., Bordoni V., Baldwin I., Bellomo R., Tetta C., et al. High-volume hemofiltration in sepsis. Theoretical basis and practical application. Nephron 2002, 92:251-258.
19. Rimmele T., Kellum J.A. High-volume hemofiltration in the intensive care unit: a blood purification therapy. Anesthesiology 2012, 116:1377-1387.
20. Cavaillon J.M. Polymyxin B for endotoxin removal in sepsis. Lancet Infect. Dis. 2011, 11:426-427.
21. Kellum J.A. Hemoadsorption therapy for sepsis syndromes. Crit. Care Med. 2003, 31:323-324.
22. Sandeman S.R., Howell C.A., Phillips G.J., Lloyd A.W., Davies J.G., Mikhalovsky S.V., et al. Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis. Biomaterials 2005, 26:7124-7131.
23. Yachamaneni S., Yushin G., Yeon S.H., Gogotsi Y., Howell C., Sandeman S., et al. Mesoporous carbide-derived carbon for cytokine removal from blood plasma. Biomaterials 2010, 31:4789-4794.
24. Howell C.A., Sandeman S.R., Phillips G.J., Lloyd A.W., Davies J.G., Mikhalovsky S.V., et al. The in vitro adsorption of cytokines by polymer-pyrolysed carbon. Biomaterials 2006, 27:5286-5291.
25. Formica M., Inguaggiato P., Bainotti S., Wratten M.L. Coupled plasma filtration adsorption. Contrib. Nephrol. 2007, 156:405-410.
26. Venkataraman R., Subramanian S., Kellum J.A. Clinical review: extracorporeal blood purification in severe sepsis. Crit. Care 2003, 7:139-145.
27. Li M., Xue J., Liu J., Kuang D., Gu Y., Lin S. Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model. Ther. Apher. Dial. Off. Peer Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther. 2011, 15:98-108.
28. Hetz H., Berger R., Recknagel P., Steltzer H. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int. J. Artif. Organs 2014, 37:422-426.
29. Campoccia D., Montanaro L., Arciola C.R. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 2013, 34:8533-8554.
30. Kang J.H., Super M., Yung C.W., Cooper R.M., Domansky K., Graveline A.R., et al. An extracorporeal blood-cleansing device for sepsis therapy. Nat. Med. 2014, 20:1211-1216.
31. Roux A.L., Sivadon-Tardy V., Bauer T., Lortat-Jacob A., Herrmann J.L., Gaillard J.L., et al. Diagnosis of prosthetic joint infection by beadmill processing of a periprosthetic specimen. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2011, 17:447-450.
32. Parakininkas D., Greenbaum L.A. Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr. Crit. Care Med. J. Soc. Crit. Care Med. World Fed. Pediatr. Intens. Crit. Care Soc. 2004, 5:269-274.
33. Roberts M., Montez A.J., Lee D.B. Component selection to optimize blood flow for continuous arteriovenous hemofiltration and dialysis. ASAIO Trans. Am. Soc. Artif. Intern. Organs 1991, 37:M382-M383.
34. Xie Y., Kolisnychenko V., Paul-Satyaseela M., Elliott S., Parthasarathy G., Yao Y., et al. Identification and characterization of Escherichia coli RS218-derived islands in the pathogenesis of E. coli meningitis. J. Infect. Dis. 2006, 194:358-364.
35. Kao J.S., Stucker D.M., Warren J.W., Mobley H.L. Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect. Immun. 1997, 65:2812-2820.
36. Neth O., Jack D.L., Dodds A.W., Holzel H., Klein N.J., Turner M.W. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 2000, 68:688-693.
37. Cesar S., Potocnik N., Stare V. Left ventricular end-diastolic pressure-volume relationship in septic rats with open thorax. Comp. Med. 2003, 53:493-497.
38. Araujo Filho I., Honorato Sobrinho A.A., Rego A.C., Garcia A.C., Fernandes D.P., Cruz T.M., et al. Influence of laparoscopy and laparotomy on gasometry, leukocytes and cytokines in a rat abdominal sepsis model. Acta Cir. Bras. Soc. Bras. Desenvolv. Pesqui. Cir. 2006, 21:74-79.
39. Brooks H.F., Osabutey C.K., Moss R.F., Andrews P.L., Davies D.C. Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction. Metab. Brain Dis. 2007, 22:353-373.
40. Yaguchi A., Lobo F.L., Vincent J.L., Pradier O. Platelet function in sepsis. J. Thromb. Haemost. JTH 2004, 2:2096-2102.
41. Ronco C. Endotoxin removal: history of a mission. Blood Purif. 2014, 37(Suppl. 1):5-8.